The global immunofluorescence assay market size is growing pervasively. The market growth attributes to the increase in biological studies in R&D for the detection of biomolecules like glycans, proteins, and small biological and non-biological molecules of various diseases. Also, immunofluorescence assays are primarily used for rapid and sensitive diagnostics of various chronic diseases such as cancer, autoimmune diseases, infectious diseases like HIV, neurological disorders such as Alzheimer's and Parkinson's diseases.
With
the intervention of the COVID-19, the immunofluorescence assay industry
overview is witnessing a massive demand across the globe. This is due to
the rising usages of immunofluorescence assays in the development of antibodies
that can detect sars-Cov-2 in patient samples. According to Market Research
Future (MRFR), the global Immunofluorescence Assay Market is expected to reach
USD 2.7 Billion by 2030 at 6.10% CAGR during the forecast period 2022-2030.
Global Immunofluorescence Assay Market – Competitive Analysis
Highly competitive, the global immunofluorescence assay market appears fragmented due to the presence of several well-established players. To gain a larger competitive advantage, players incorporate strategies such as mergers & acquisitions, collaborations, expansion, and product/technology launch. Top players make huge investments for R&D and clinical trials to develop these assays. Pharmaceutical companies are the largest investors in the immunofluorescence assay market.
Major Players:
The global immunofluorescence assay market Players leading include Abcam plc., Thermo Fisher Scientific, BioLegend, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., BioTek Instruments, Inc., Bio-Rad Laboratories, Inc., Zyagen Cell Signaling Technology, Inc., PerkinElmer Inc., Becton Dickinson and Company, Merck, Agilent Technologies, TCS Biosciences Ltd, and Maxvision Biosciences Inc., among others.
Advancements
in medical technology, alongside the increasing R&D funding by industry
leaders and governments, boost the market growth. Additionally, rising numbers
of preclinical research, alongside the rising studies on antibody therapies,
advanced drug discoveries, and
oncology diseases, accelerate the market growth. Growing collaborations between
research institutes and biotechnology companies are expected to drive the
growth of the immunofluorescence assay market.
Conversely,
the high cost of immunofluorescence assay products such as diagnostic kits is
expected to restrict the market growth during the forecast period. Also,
factors such as risks of cross contaminations and shortage of skilled labor
& weak detection signals are estimated to impede the growth of this
market. Nevertheless, growing advancements in biotechnology & medical
science would support the growth of the market, bringing about cost-effective
immunofluorescence assay.
Global Immunofluorescence Assay Market – Segmentation
The
report is segmented into five dynamics;
By Technique: Primary (Direct)
Immunofluorescence Assays and Secondary (Indirect) Immunofluorescence Assays
(Salt split technique, Antigenic mapping method, Double Staining method), Micro
Immunofluorescence.
By Product Type: Antibodies, Kits & Reagents,
Instruments, Microscopes, Imaging Analysis Systems, Labeling dyes, Species
Product Type, and others.
By Application: Clinical Research, Clinical
Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune
Diseases, Neurological Diseases, Research & Development, and others.
By End-User: Biotechnology Companies,
Hospitals & Research Institutes, Contract Research Organizations,
Diagnostic centers, and others.
By Regions: Americas, Europe, Asia
Pacific, and Rest-of-the-World.
Global Immunofluorescence Assay Market – Regional Analysis
North
America dominates the global immunofluorescence assay market. The largest
market share attributes to the high prevalence of chronic diseases and rising
R&D investments within this region. Also, the rising adoption of advanced
systems for early diagnosis of diseases drives the regional market growth.
Moreover, the advancement in the development techniques and increasing use of
nanotechnology in the development of immunofluorescence assay fostered the
growth of the regional market.
The
US, among other North American countries, holds the largest share in the
regional market. Besides, the presence of vast numbers of biotechnology &
pharmaceutical companies impacts the regional market growth positively. The
North American immunofluorescence assay market is estimated to retain its
leading position throughout the assessment period.
Europe
stands second in the immunofluorescence assay market. The market is driven by
the increasing prevalence of myriads of chronic diseases such as cancer and the
rapidly growing biotechnology sector in Europe. Moreover, substantial R&D
investments by the public and private sectors, alongside the increasing R &
D in biotechnology, foster the market growth in the region. The European
immunofluorescence assay market is projected to create a substantial revenue
pocket over the review period.
The
immunofluorescence assay market in the Asia Pacific region is growing rapidly.
Factors such as the growing patient pool, high incidence of chronic diseases,
developing healthcare infrastructure, and increasing R&D activities in the
biotechnology sector influence the market in this region. Also, the presence of
major market players in China, India, and Japan drive market growth. Rising
government initiatives increase the size of the immunofluorescence assay market
in the region.
The
region witnesses rising developments of immunofluorescence assay products,
while several products are under the pipeline, which is carried out under
license agreements. The APAC immunofluorescence assay market is expected to
grow at an impressive CAGR during the predicted period.
About US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
